| Particulars |
|
|
|
| Company Name
| Fredun Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
5.37 |
B.V. (₹) |
443.70 |
| Sales(₹ Cr.) |
451.71 |
NP (₹ Cr.) |
20.81 |
| NP Var (%) |
33.00 |
Div% |
7.00 |
| CPS(₹) |
47.10 |
EPS (₹) |
38.80 |
| Traded Value(₹ Lakhs) |
137.97 |
52 Week High |
1,999.00 |
| 52 Week Low |
635.00 |
Price BSE |
1,534.00 |
| P/C Ratio |
32.60 |
P/E Ratio |
39.60 |
| Price Vs.BV |
3.46 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
159.93 |
| NP(₹ Cr.) |
10.48 |
NP Var % |
96.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
388.30 |
| OPM |
11.88 |
NP |
17.69 |
| NP Var (%) |
81.12 |
EPS |
63.45 |
| PE |
24.18 |
|
|